Aloha Medicinals Sustainability Profile
Aloha Medicinals, a leading name in the biotechnology sector, is headquartered in the United States, with significant operations across North America and beyond. Founded in 2000, the company has established itself as a pioneer in the cultivation and production of medicinal mushrooms, focusing on high-quality mycelium and fruiting body extracts. Aloha Medicinals is renowned for its unique, scientifically-backed products that cater to the health and wellness market, including dietary supplements and functional foods. Their commitment to sustainability and innovation has positioned them as a trusted supplier in the industry, achieving notable milestones such as partnerships with major health brands. With a strong emphasis on research and development, Aloha Medicinals continues to lead the way in harnessing the therapeutic potential of mushrooms, setting a benchmark for quality and efficacy in the market.
DitchCarbon Score
How does Aloha Medicinals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aloha Medicinals's score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aloha Medicinals's reported carbon emissions
Aloha Medicinals, headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary of Aloha Medicinals, Inc., and as such, it does not inherit emissions data from its parent organization. In terms of climate commitments, Aloha Medicinals has not established any documented reduction targets or initiatives, nor does it participate in recognised frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Consequently, there are no specific climate pledges or commitments to report. As the company continues to develop its sustainability strategy, it may consider setting measurable targets in the future to align with industry standards and contribute to global climate goals.
How Carbon Intensive is Aloha Medicinals's Industry?
How Carbon Intensive is Aloha Medicinals's Location?
Aloha Medicinals's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aloha Medicinals has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
